Security key
74346M406
PROMIS NEUROSCIENCES INC. - Common Shares, No Par Value per Share (PMN)
CUSIP: 74346M406
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Shares, No Par Value per Share
- Shares outstanding
- 9,550,370
- Total 13F shares
- 9,325,986
- Share change
- -421,267
- Total reported value
- $6,489,664
- Price per share
- $0.70
- Number of holders
- 17
- Value change
- -$305,401
- Number of buys
- 4
- Number of sells
- 7
Report period
Q1 2025
Institutions
17
Top holders
10
PMN full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
ProMIS Neurosciences Inc. SEC filings
ProMIS Neurosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74346M406
Recent filing periods:
Top shareholders of PMN - PROMIS NEUROSCIENCES INC. - Common Shares, No Par Value per Share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC |
13F
|
Company |
28%
|
2,645,128
|
$2,507,052 | — | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
26%
|
2,509,977
|
$2,378,956 | — | 31 Dec 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
20%
|
1,929,297
|
$1,828,588 | — | 31 Dec 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
17%
|
1,592,605
|
$1,509,471 | — | 31 Dec 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
6.1%
|
581,395
|
$551,046 | — | 31 Dec 2024 | |
| Allostery Investments LP |
13F
|
Company |
2%
|
195,111
|
$184,926 | — | 31 Dec 2024 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
1.7%
|
160,207
|
$151,652 | — | 31 Dec 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.32%
|
30,366
|
$28,744 | — | 31 Dec 2024 | |
| Hara Capital LLC |
13F
|
Company |
0.31%
|
29,416
|
$27,880 | — | 31 Dec 2024 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.27%
|
26,042
|
$24,683 | — | 31 Dec 2024 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.14%
|
13,583
|
$12,874 | — | 31 Dec 2024 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.13%
|
12,122
|
$11,482 | — | 31 Dec 2024 | |
| Claret Asset Management Corp |
13F
|
Company |
0.12%
|
11,330
|
$11,000 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
5,487
|
$5,000 | — | 31 Dec 2024 | |
| Sandy Spring Bank |
13F
|
Company |
0.03%
|
3,300
|
$3,128 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,666
|
$1,578 | — | 31 Dec 2024 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
133
|
$126 | — | 31 Dec 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
88
|
$83 | — | 31 Dec 2024 | |
| Gail M. Farfel |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
108,384
mixed-class rows
|
$256,091 | — | 23 Aug 2023 | |
| Gavin T. Malenfant |
3/4/5
|
Chief Operating Officer, Director |
—
mixed-class rows
|
17,820
mixed-class rows
|
$12,342 | — | 26 Oct 2023 | |
| Daniel E. Geffken |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
2,500
|
— | — | 26 Oct 2023 |
Institutional Holders of PROMIS NEUROSCIENCES INC. - Common Shares, No Par Value per Share (PMN) as of Q1 2025
As of 31 Mar 2025,
PROMIS NEUROSCIENCES INC. - Common Shares, No Par Value per Share (PMN) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,325,986 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, ARMISTICE CAPITAL, LLC, SPHERA FUNDS MANAGEMENT LTD., Ally Bridge Group (NY) LLC, Altium Capital Management LLC, Allostery Investments LP, BANK OF MONTREAL /CAN/, IEQ CAPITAL, LLC, Fiduciary Trust Co, and HEIGHTS CAPITAL MANAGEMENT, INC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
18
Q1 2025 holders
17
Holder diff
-1
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.